Publications: Cancer treatment

J. Veatch, W. Gwin, E.T. Hall, S. Bhatia, S.M. Lee, L.M. Tachiki, S.S. Tykodi, N.J. Miller, K.G. Paulson, F.W. Schmitz, A. Heit, T. Zhang, A. Rizzi, M. Iuliano, B. Seaton, G. Roy, B. Lee, L. Martin, M. Walker, A. Harley, A.I. Safo, S.A. Danziger, H. Tang, P. Le, L. Price, G. Sadeh, B. Hoane, S. Stockwell, B. Sarkis, N. Levato, A. Vaidya, N. Sood, C. Yeung, E.W. Newell, R.K. Strong, D. Heckerman, A.G. Chapuis. A phase I clinical trial of a personalized neoantigen vaccine in PD-1 inhibitor refractory metastatic melanoma. The 40th Annual Meeting of the Society for Immunotherapy of Cancer. Washington DC, October 2025.

F. Mazziotta, J. Veatch, F. Schmitz, T. Zhang, A. Rizzi, L. Martin, N. Singhi, B. Lee, J. Sung, A. Heit, M. Iuliano, A. Harley, A.I. Safo, S. Danziger, H. Tang, A. Codd, P. Le, S. Jenes, E. Wilcox, C. Smith, K. Finton, L. Price, G. Sadeh, B. Hoane, S. Stockwell, B. Sarkis, N. Sood, M. Walker, R.K. Strong, E.W. Newell, D. Heckerman, and A. Chapuis, A personalized neoantigen vaccine induces anti-tumor T cell responses in patients with PD-1/PD-L1 inhibitor refractory metastatic melanoma. The 40th Annual Meeting of the Society for Immunotherapy of Cancer. Washington DC, October 2025.